{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:22:36Z","timestamp":1794964956861,"version":"4.9.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s40620-020-00938-3","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T10:31:06Z","timestamp":1613039466000},"page":"1147-1156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis"],"prefix":"10.1093","volume":"34","author":[{"given":"Fernando Louzada","family":"Strufaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precil Diego Miranda de Menezes","family":"Menezes Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Bitencourt","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Woronik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Barreira","family":"Cavalcante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise Maria Avancini Costa","family":"Malheiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lect\u00edcia Barbosa","family":"Jorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"issue":"5","key":"938_CR1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH (2017) Update on Lupus Nephritis. Clin J Am Soc Nephrol 12(5):825\u2013835","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"938_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","volume":"15","author":"N Danchenko","year":"2006","unstructured":"Danchenko N, Satia JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15(5):308\u2013318","journal-title":"Lupus"},{"issue":"12","key":"938_CR3","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1177\/0961203310374305","volume":"19","author":"E Osio-Salido","year":"2010","unstructured":"Osio-Salido E, Manapat-Reyes H (2010) Epidemiology of systemic lupus erythematosus in Asia. Lupus 19(12):1365\u20131373","journal-title":"Lupus"},{"issue":"3","key":"938_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1191\/0961203302lu158oa","volume":"11","author":"HM Bastian","year":"2002","unstructured":"Bastian HM, Roseman JM, McGwin G Jr et al (2002) Lupus in Minority populations: Nature vs nurture: Systemic lupus erythematosus in three ethnic groups .XII. Risk factors for lupus nephritis after diagnosis. Lupus 11(3):152\u2013160","journal-title":"Lupus"},{"issue":"4","key":"938_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE et al (2018) Revision of the ISN\/RPS classification for lupus nephritis: modified NIH activity and chronicity indices and clarification of definitions. Kidney Int 93(4):789\u2013796","journal-title":"Kidney Int"},{"issue":"8","key":"938_CR6","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/art.23662","volume":"58","author":"D Cohen","year":"2008","unstructured":"Cohen D, Koopmans M, Kremer Hovinga IC et al (2008) Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum 58(8):2460\u20132469","journal-title":"Arthritis Rheum"},{"issue":"1","key":"938_CR7","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1186\/ar4142","volume":"15","author":"D Song","year":"2013","unstructured":"Song D, Wu LH, Wang FM et al (2013) The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther 15(1):R12","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"938_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/RHU.0000000000000425","volume":"22","author":"A Barrera-Vargas","year":"2016","unstructured":"Barrera-Vargas A, Rosado-Canto R, Merayo-Chalico J et al (2016) Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes. J Clin Rheumatol 22(5):235\u2013240","journal-title":"J Clin Rheumatol"},{"issue":"18","key":"938_CR9","doi-asserted-by":"publisher","first-page":"e3595","DOI":"10.1097\/MD.0000000000003595","volume":"95","author":"QT Li","year":"2016","unstructured":"Li QT, Yu F, Zhou FD, Zhao MH et al (2016) Plasmapheresis is associated with better renal outcomes in lupus nephritis patients with thrombotic microangiopathy. Medicine (Baltimore) 95(18):e3595","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"938_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.ackd.2019.08.012","volume":"26","author":"ES Kotzen","year":"2019","unstructured":"Kotzen ES, Roy S, Jain K (2019) Antiphospholipid syndrome nephropathy and other thrombotic microangiopathies among patients with systemic lupus erythematosus. Adv Chronic Kidney Dis 26(5):376\u2013386","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"938_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"M Scully","year":"2017","unstructured":"Scully M, Cataland S, Coppo P et al (2017) International Working Group for Thrombotic. Thrombocytopenic Purpura. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15(2):312\u2013322","journal-title":"J Thromb Haemost"},{"issue":"7","key":"938_CR12","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666","journal-title":"N Engl J Med"},{"issue":"4","key":"938_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/rheumatology\/keq311","volume":"50","author":"MH Chen","year":"2010","unstructured":"Chen MH, Chen MH, Chen WS et al (2010) Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan. Rheumatology 50(4):768\u2013775","journal-title":"Rheumatology"},{"issue":"2","key":"938_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","volume":"95","author":"CDJ Rovin","year":"2019","unstructured":"Rovin CDJ, Cattran DC et al (2019) Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 95(2):281\u2013295","journal-title":"Kidney Int"},{"issue":"9","key":"938_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D et al (2019) European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78(9):1151\u20131159","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"938_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"issue":"33","key":"938_CR17","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W et al (2018) 2018 ESC\/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39(33):3021\u20133104","journal-title":"Eur Heart J"},{"key":"938_CR18","volume-title":"Nutritional anaemias: Report of a WHO scientific group","author":"World Health Organization","year":"1968","unstructured":"World Health Organization (1968) Nutritional anaemias: Report of a WHO scientific group. World Health Organization, Geneva, Switzerland"},{"issue":"4","key":"938_CR19","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1378\/chest.13-0121","volume":"144","author":"DR Williamson","year":"2013","unstructured":"Williamson DR, Albert M, Heels-Ansdell D et al (2013) PROTECT collaborators, the Canadian Critical Care Trials Group, and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 144(4):1207\u20131215","journal-title":"Chest"},{"issue":"1","key":"938_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2010111130","volume":"23","author":"K El Karoui","year":"2011","unstructured":"El Karoui K, Hill GS, Karras A et al (2011) A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy. J Am Soc Nephrol 23(1):137\u2013148","journal-title":"J Am Soc Nephrol"},{"key":"938_CR21","unstructured":"Goodship TH, Cook HT, Fakhouri F, et al. (2017) Conference Participants. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 91(3):539\u2013551"},{"issue":"2","key":"938_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0272-6386(12)80885-7","volume":"18","author":"G Banfi","year":"1991","unstructured":"Banfi G, Bertani T, Boeri V et al (1991) Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Am J Kidney Dis 18(2):240\u2013248","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"938_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0046-8177(85)80212-4","volume":"16","author":"T Tsumagari","year":"1985","unstructured":"Tsumagari T, Fukumoto S, Kinjo M et al (1985) Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus. Hum Pathol 16(1):43\u201349","journal-title":"Hum Pathol"},{"issue":"4","key":"938_CR24","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/ki.2012.409","volume":"83","author":"L-H Wu","year":"2013","unstructured":"Wu L-H, Yu F, Tan Y et al (2013) Inclusion of renal vascular lesions in the 2003 ISN\/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83(4):715\u2013723","journal-title":"Kidney Int"},{"issue":"11","key":"938_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1177\/0961203307083279","volume":"16","author":"SJ Li","year":"2007","unstructured":"Li SJ, Liu ZH, Zen CH et al (2007) Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection. Lupus 16(11):875\u2013880","journal-title":"Lupus"},{"issue":"11","key":"938_CR26","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3899\/jrheum.180773","volume":"46","author":"C Li","year":"2019","unstructured":"Li C, Yap DYH, Chan G et al (2019) Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy. J Rheumatol 46(11):1478\u20131484","journal-title":"J Rheumatol"},{"key":"938_CR27","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G (2009) Atypical hemolytic-uremic syndrome. N Engl J Med 361:1676\u20131687","journal-title":"N Engl J Med"},{"issue":"1","key":"938_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF00915156","volume":"8","author":"M Brai","year":"1988","unstructured":"Brai M, Misiano G, Maringhini S et al (1988) Combined homozygous factor H and heterozygous C2 deficiency in an Italian family. J Clin Immunol 8(1):50\u201356","journal-title":"J Clin Immunol"},{"issue":"4\u20135","key":"938_CR29","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s002510050631","volume":"51","author":"P S\u00e1nchez-Corral","year":"2000","unstructured":"S\u00e1nchez-Corral P, Bellavia D, Amico L et al (2000) Molecular basis for factor H and FHL-1 deficiency in an Italian family. Immunogenetics 51(4\u20135):366\u2013369","journal-title":"Immunogenetics"},{"issue":"6","key":"938_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1365-3083.2001.00931.x","volume":"53","author":"N Amadei","year":"2001","unstructured":"Amadei N, Baracho G, Nudelman V et al (2001) Inherited complete factor I deficiency associated with systemic lupus erythematosus, higher susceptibility to infection and low levels of factor H. Scand J Immunol 53(6):615\u2013621","journal-title":"Scand J Immunol"},{"issue":"12","key":"938_CR31","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1007\/s10067-017-3823-2","volume":"36","author":"MI De Holanda","year":"2017","unstructured":"De Holanda MI, Porto LC, Wagner T et al (2017) Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review. Clin Rheumatol 36(12):2859\u20132867","journal-title":"Clin Rheumatol"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00938-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:55:17Z","timestamp":1777564517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/34\/4\/1147\/8325871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["938"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00938-3","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"11 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Complaince with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human and animal participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration  and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}